indomethacin has been researched along with Enteritis in 43 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Enteritis: Inflammation of any segment of the SMALL INTESTINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ingestion of DON mycotoxin at concentrations representative of human real-world exposure worsened the development of indomethacin-induced enteritis and colitis-associated CRC in mice." | 8.31 | Low dose dietary contamination with deoxynivalenol mycotoxin exacerbates enteritis and colorectal cancer in mice. ( Beury, D; Body-Malapel, M; Caboche, S; Desai, MS; Djouina, M; Dubuquoy, L; Hot, D; Launay, D; Lecointe, K; Steimle, A; Vignal, C; Waxin, C, 2023) |
| " We evaluated the role of the pro-inflammatory cytokine TNF-alpha on nitric oxide synthase (NOS) expression in indomethacin-induced jejunoileitis in rats." | 7.76 | TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. ( Levine, RA; Nandi, J; Saud, B; Yang, ZJ; Zinkievich, JM, 2010) |
| " Therefore, we evaluated the biological effects of lansoprazole, a PPI used in the clinical area, in the setting of experimental rat non-steroidal anti-inflammatory drug-induced enteritis." | 7.73 | Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. ( Ichikawa, H; Kuroda, M; Naito, Y; Okanoue, T; Okuda, T; Takagi, T; Yoshida, N; Yoshikawa, T, 2006) |
| " Rats with indomethacin-induced enteritis were orally administered Rb, Mn, and Zn as tracers." | 7.72 | Use of rubidium, manganese, and zinc as tracers to measure intestinal permeability by PIXE analysis: basal study in an experimental enteritis model. ( Imaseki, H; Joshima, H; Nakao, K; Saito, Y; Suzuki, Y; Tamanoi, I, 2004) |
| "Ingestion of DON mycotoxin at concentrations representative of human real-world exposure worsened the development of indomethacin-induced enteritis and colitis-associated CRC in mice." | 4.31 | Low dose dietary contamination with deoxynivalenol mycotoxin exacerbates enteritis and colorectal cancer in mice. ( Beury, D; Body-Malapel, M; Caboche, S; Desai, MS; Djouina, M; Dubuquoy, L; Hot, D; Launay, D; Lecointe, K; Steimle, A; Vignal, C; Waxin, C, 2023) |
| "β-casofensin exerts protective effects in indomethacin-induced enteritis through preservation of goblet cells and improvement in wound healing." | 3.83 | Protective effects of β-casofensin, a bioactive peptide from bovine β-casein, against indomethacin-induced intestinal lesions in rats. ( Benoit, B; Bessette, C; Bruno, J; Estienne, M; Ferrier, L; Léonil, J; Plaisancié, P; Sekkal, S; Théodorou, V, 2016) |
| " Administration of indomethacin, a non-steroidal anti-inflammatory drug (NSAID) that causes enteritis, led to rapid and restricted proximal small intestinal injuries in Gata4 mutant mice as opposed to control mice." | 3.83 | Gata4 is critical to maintain gut barrier function and mucosal integrity following epithelial injury. ( Allaire, JM; Asselin, C; Bélanger, É; Boudreau, F; Bruneau, J; Gendron, FP; Jones, C; Lepage, D; Menendez, A; Perreault, N; Tremblay, S, 2016) |
| " This study aimed to investigate the effects of hemin, an HO-1 inducer, on indomethacin-induced enteritis in mice." | 3.79 | Hemin ameliorates indomethacin-induced small intestinal injury in mice through the induction of heme oxygenase-1. ( Fukui, A; Handa, O; Harusato, A; Higashimura, Y; Hirai, Y; Ichikawa, H; Kamada, K; Katada, K; Kugai, M; Mizusima, K; Naito, Y; Takagi, T; Tsuji, T; Uchiyama, K; Yagi, N; Yamada, S; Yoriki, H; Yosikawa, T, 2013) |
| " We evaluated the role of the pro-inflammatory cytokine TNF-alpha on nitric oxide synthase (NOS) expression in indomethacin-induced jejunoileitis in rats." | 3.76 | TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. ( Levine, RA; Nandi, J; Saud, B; Yang, ZJ; Zinkievich, JM, 2010) |
| " Therefore, we evaluated the biological effects of lansoprazole, a PPI used in the clinical area, in the setting of experimental rat non-steroidal anti-inflammatory drug-induced enteritis." | 3.73 | Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. ( Ichikawa, H; Kuroda, M; Naito, Y; Okanoue, T; Okuda, T; Takagi, T; Yoshida, N; Yoshikawa, T, 2006) |
| " Rats with indomethacin-induced enteritis were orally administered Rb, Mn, and Zn as tracers." | 3.72 | Use of rubidium, manganese, and zinc as tracers to measure intestinal permeability by PIXE analysis: basal study in an experimental enteritis model. ( Imaseki, H; Joshima, H; Nakao, K; Saito, Y; Suzuki, Y; Tamanoi, I, 2004) |
| "We investigated the effect of dexamethasone on indomethacin-induced ulceration in the rat." | 3.69 | Dexamethasone promotes ulcer plugging in experimental enteritis. ( Anthony, A; Dhillon, AP; Pounder, RE; Sim, R; Wakefield, AJ, 1994) |
| "An ulcerative enterocolitis was induced in dogs by two drugs; cinchophen given intravenously or indomethacin given orally." | 3.66 | Ulcerative enterocolitis in dogs induced by drugs. ( Hetenyi, C; Orizaga, M; Rowsell, H; Stewart, TH, 1980) |
| " However, its low oral bioavailability is a major obstacle to its potential use." | 1.48 | Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide. ( Chen, YC; Wang, CC; Wu, MT; Wu, YT; Yen, CC, 2018) |
| "Cotreatment with omeprazole did not reduce indomethacin-induced intestinal bleeding." | 1.42 | Suppression of contractile activity in the small intestine by indomethacin and omeprazole. ( Bhattarai, D; Dial, EJ; Lichtenberger, LM; Phan, TM; Uray, K, 2015) |
| "Oral IND@RNP(O) administration is a useful approach for improving the oral bioavailability of IND and suppressing its adverse effects." | 1.40 | Indomethacin-loaded redox nanoparticles improve oral bioavailability of indomethacin and suppress its small intestinal inflammation. ( Chonpathompikunlert, P; Matsui, H; Nagasaki, Y; Sha, S; Vong, LB; Yoshitomi, T, 2014) |
| "The ovalbumin serum level was higher in indomethacin-treated mice and the increase was proportional to the dose of indomethacin." | 1.29 | Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice. ( Belaiche, J; Deprez, M; Franchimont, D; Lamproye, A; Louis, E; Mahieu, P; Schaaf, N, 1996) |
| "Indomethacin treatment significantly decreased bile acid-independent bile flow and biliary secretion of bile acid and cholesterol, while increasing biliary phospholipid output in vivo." | 1.29 | Bile secretion in rats with indomethacin-induced intestinal inflammation. ( Hayakawa, T; Hoshino, M; Inagaki, T; Kamiya, Y; Miyaji, M; Mizuno, K; Nakazawa, T; Ohhara, H; Takeuchi, T; Uchida, A; Yamada, H; Yamada, T, 1996) |
| "Indomethacin treated animals demonstrated significantly less polymorphonuclear leukocyte infiltration and decreased degeneration." | 1.28 | The effect of indomethacin on acute radiation induced gastrointestinal injury: a morphologic study. ( Halter, SA; Rose, PG; Su, CM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (9.30) | 18.7374 |
| 1990's | 13 (30.23) | 18.2507 |
| 2000's | 12 (27.91) | 29.6817 |
| 2010's | 13 (30.23) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Djouina, M | 1 |
| Waxin, C | 1 |
| Caboche, S | 1 |
| Lecointe, K | 1 |
| Steimle, A | 1 |
| Beury, D | 1 |
| Desai, MS | 1 |
| Hot, D | 1 |
| Dubuquoy, L | 1 |
| Launay, D | 1 |
| Vignal, C | 1 |
| Body-Malapel, M | 1 |
| Yen, CC | 1 |
| Chen, YC | 1 |
| Wu, MT | 1 |
| Wang, CC | 1 |
| Wu, YT | 1 |
| Yoshitomi, T | 1 |
| Sha, S | 1 |
| Vong, LB | 1 |
| Chonpathompikunlert, P | 1 |
| Matsui, H | 1 |
| Nagasaki, Y | 1 |
| Ciobanu, L | 2 |
| Taulescu, M | 1 |
| Prundus, R | 1 |
| Diaconu, B | 1 |
| Andreica, V | 1 |
| Catoi, C | 2 |
| Pascu, O | 1 |
| Tantau, M | 1 |
| Yamamoto, A | 1 |
| Itoh, T | 1 |
| Nasu, R | 1 |
| Nishida, R | 1 |
| Lichtenberger, LM | 1 |
| Bhattarai, D | 1 |
| Phan, TM | 1 |
| Dial, EJ | 1 |
| Uray, K | 1 |
| Bessette, C | 1 |
| Benoit, B | 1 |
| Sekkal, S | 1 |
| Bruno, J | 1 |
| Estienne, M | 1 |
| Léonil, J | 1 |
| Ferrier, L | 1 |
| Théodorou, V | 1 |
| Plaisancié, P | 1 |
| Kwak, DS | 1 |
| Lee, OY | 1 |
| Lee, KN | 1 |
| Jun, DW | 1 |
| Lee, HL | 1 |
| Yoon, BC | 1 |
| Choi, HS | 1 |
| Lepage, D | 1 |
| Bélanger, É | 1 |
| Jones, C | 1 |
| Tremblay, S | 1 |
| Allaire, JM | 1 |
| Bruneau, J | 1 |
| Asselin, C | 1 |
| Perreault, N | 1 |
| Menendez, A | 1 |
| Gendron, FP | 1 |
| Boudreau, F | 1 |
| Okayama, T | 1 |
| Yoshida, N | 3 |
| Uchiyama, K | 2 |
| Takagi, T | 4 |
| Ichikawa, H | 4 |
| Yoshikawa, T | 3 |
| Nandi, J | 2 |
| Saud, B | 2 |
| Zinkievich, JM | 2 |
| Yang, ZJ | 1 |
| Levine, RA | 2 |
| Kakimoto, K | 1 |
| Takai, S | 1 |
| Murano, M | 1 |
| Ishida, K | 1 |
| Yoda, Y | 1 |
| Inoue, T | 1 |
| Jin, D | 1 |
| Umegaki, E | 1 |
| Higuchi, K | 1 |
| Jorge, E | 1 |
| Vergara, P | 2 |
| Martin, MT | 2 |
| Yoriki, H | 1 |
| Naito, Y | 3 |
| Mizusima, K | 1 |
| Hirai, Y | 1 |
| Harusato, A | 1 |
| Yamada, S | 1 |
| Tsuji, T | 1 |
| Kugai, M | 1 |
| Fukui, A | 1 |
| Higashimura, Y | 1 |
| Katada, K | 1 |
| Kamada, K | 1 |
| Handa, O | 2 |
| Yagi, N | 1 |
| Yosikawa, T | 1 |
| Nadăş, GC | 1 |
| Taulescu, MA | 1 |
| Fiţ, NI | 1 |
| Flore, C | 1 |
| Răpuntean, S | 1 |
| Bouari, CM | 1 |
| Porras, M | 1 |
| Soler, M | 1 |
| Nakao, K | 1 |
| Suzuki, Y | 1 |
| Imaseki, H | 1 |
| Joshima, H | 1 |
| Tamanoi, I | 1 |
| Saito, Y | 1 |
| Kuroda, M | 1 |
| Okuda, T | 2 |
| Okanoue, T | 1 |
| Vymiatina, ZK | 1 |
| Ivanova, LA | 1 |
| Krylova, SG | 1 |
| Palma, DT | 1 |
| Kokura, S | 1 |
| Stewart, TH | 1 |
| Hetenyi, C | 1 |
| Rowsell, H | 1 |
| Orizaga, M | 1 |
| Anthony, A | 2 |
| Dhillon, AP | 1 |
| Sim, R | 1 |
| Pounder, RE | 1 |
| Wakefield, AJ | 1 |
| Yamada, T | 4 |
| Deitch, E | 1 |
| Specian, RD | 1 |
| Perry, MA | 1 |
| Sartor, RB | 1 |
| Grisham, MB | 2 |
| Woodard, JP | 1 |
| Chen, W | 1 |
| Keku, EO | 1 |
| Liu, SC | 1 |
| Lecce, JG | 1 |
| Rhoads, JM | 1 |
| Louis, E | 1 |
| Franchimont, D | 1 |
| Deprez, M | 1 |
| Lamproye, A | 1 |
| Schaaf, N | 1 |
| Mahieu, P | 1 |
| Belaiche, J | 1 |
| Kremer, JM | 1 |
| Malamood, H | 1 |
| Maliakkal, B | 1 |
| Rodgers, JB | 1 |
| Ross, JS | 1 |
| Cooper, JA | 1 |
| Battarbee, HD | 1 |
| Johnson, GG | 1 |
| Zavecz, JH | 1 |
| Hoshino, M | 3 |
| Hayakawa, T | 3 |
| Kamiya, Y | 1 |
| Ohhara, H | 2 |
| Mizuno, K | 1 |
| Yamada, H | 2 |
| Nakazawa, T | 2 |
| Inagaki, T | 2 |
| Uchida, A | 3 |
| Miyaji, M | 2 |
| Takeuchi, T | 2 |
| Kullmann, F | 1 |
| Gross, V | 1 |
| Rüschoff, J | 1 |
| Arndt, H | 1 |
| Benda, W | 1 |
| Winkler von Mohrenfels, A | 1 |
| Schölmerich, J | 1 |
| Iida, M | 1 |
| Ogasawara, T | 1 |
| Hasegawa, C | 1 |
| Murasaki, G | 1 |
| Hirata, A | 1 |
| László, F | 2 |
| Whittle, BJ | 2 |
| Boushey, RP | 1 |
| Yusta, B | 1 |
| Drucker, DJ | 1 |
| Evans, SM | 1 |
| Beck, PL | 1 |
| Xavier, R | 1 |
| Lu, N | 1 |
| Nanda, NN | 1 |
| Dinauer, M | 1 |
| Podolsky, DK | 1 |
| Seed, B | 1 |
| Ruh, J | 1 |
| Vogel, F | 1 |
| Schmidt, E | 1 |
| Stadnyk, AW | 1 |
| Dollard, C | 1 |
| Issekutz, TB | 1 |
| Issekutz, AC | 1 |
| Sigthorsson, G | 1 |
| Simpson, RJ | 1 |
| Walley, M | 1 |
| Foster, R | 1 |
| Hotz-Behoftsitz, C | 1 |
| Palizban, A | 1 |
| Pombo, J | 1 |
| Watts, J | 1 |
| Morham, SG | 1 |
| Bjarnason, I | 1 |
| Fang, WF | 1 |
| Broughton, A | 1 |
| Jacobson, ED | 1 |
| Rose, PG | 1 |
| Halter, SA | 1 |
| Su, CM | 1 |
| Brunsson, I | 1 |
| Calabro, JJ | 1 |
| Garg, SL | 1 |
| Khoury, MI | 1 |
| Long, JA | 1 |
| Birbara, CA | 1 |
1 trial available for indomethacin and Enteritis
| Article | Year |
|---|---|
Fish oil dietary supplementation for prevention of indomethacin induced gastric and small bowel toxicity in healthy volunteers.
Topics: Adult; Biopsy; Double-Blind Method; Endoscopy; Enteritis; Female; Fish Oils; Food, Fortified; Gastri | 1996 |
42 other studies available for indomethacin and Enteritis
| Article | Year |
|---|---|
Low dose dietary contamination with deoxynivalenol mycotoxin exacerbates enteritis and colorectal cancer in mice.
Topics: Animals; Colitis; Colorectal Neoplasms; Diet; Enteritis; Humans; Indomethacin; Mice; Mycotoxins | 2023 |
Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological | 2018 |
Indomethacin-loaded redox nanoparticles improve oral bioavailability of indomethacin and suppress its small intestinal inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chromatography, High Pres | 2014 |
Effects of rifaximin on indomethacin-induced intestinal damage in guinea-pigs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Enteritis; Female; Gastrointestinal Agents; Guinea | 2014 |
Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats.
Topics: Alginates; Anemia; Animals; Anti-Ulcer Agents; Atrophy; Bacterial Translocation; Biomarkers; Capilla | 2014 |
Suppression of contractile activity in the small intestine by indomethacin and omeprazole.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Enteritis; Gastrointestinal Hemorrhage | 2015 |
Protective effects of β-casofensin, a bioactive peptide from bovine β-casein, against indomethacin-induced intestinal lesions in rats.
Topics: Administration, Oral; Animals; Caseins; Cattle; Enteritis; HT29 Cells; Humans; Indomethacin; Intesti | 2016 |
The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose | 2016 |
Gata4 is critical to maintain gut barrier function and mucosal integrity following epithelial injury.
Topics: Animals; Claudins; Enteritis; GATA4 Transcription Factor; Gene Expression Regulation; Indomethacin; | 2016 |
Mast cells are involved in the pathogenesis of indomethacin-induced rat enteritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CXCL1; Enteritis; Indomethacin; Intestin | 2009 |
TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis.
Topics: Animals; Dose-Response Relationship, Drug; Enteritis; Hyperbaric Oxygenation; Ileitis; Ileum; Indome | 2010 |
Significance of chymase-dependent matrix metalloproteinase-9 activation on indomethacin-induced small intestinal damages in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chymases; Enteritis; Enzyme Inhibitors; Indomethac | 2010 |
Ileal inducible nitric oxide synthase mRNA expression in response to stress is modified in Sprague-Dawley rats exposed to a previous intestinal inflammation.
Topics: Animals; Bacterial Translocation; Defecation; Enteritis; Gastrointestinal Motility; Ileum; Immersion | 2012 |
Hemin ameliorates indomethacin-induced small intestinal injury in mice through the induction of heme oxygenase-1.
Topics: Animals; Blotting, Western; Chemokines; Cytokines; Disease Models, Animal; DNA Primers; Enteritis; E | 2013 |
The interplay between NSAIDs and Candida albicans on the gastrointestinal tract of guinea pigs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Candida albicans; Enteritis; Female; Gastrointesti | 2013 |
Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Bacterial Infections; Bac | 2004 |
Use of rubidium, manganese, and zinc as tracers to measure intestinal permeability by PIXE analysis: basal study in an experimental enteritis model.
Topics: Animals; Crohn Disease; Enteritis; Indomethacin; Inflammation; Intestinal Absorption; Intestine, Sma | 2004 |
Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine | 2006 |
[Experimental study of the impact of a single use of indometacine on the morphological structure of the mucous coat of the stomach and small intestine].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Enteritis; Gastric Mucosa; Indomethacin; Intestina | 2006 |
5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blotting, Western; Cyclooxygenase Inhi | 2008 |
CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzimida | 2008 |
Ulcerative enterocolitis in dogs induced by drugs.
Topics: Animals; Colitis; Dogs; Enteritis; Female; Indomethacin; Intestinal Diseases; Male; Peyer's Patches; | 1980 |
Dexamethasone promotes ulcer plugging in experimental enteritis.
Topics: Animals; Dexamethasone; Enteritis; Fibrin; Hematologic Tests; Indomethacin; Intestinal Mucosa; Jejun | 1994 |
Mechanisms of acute and chronic intestinal inflammation induced by indomethacin.
Topics: Acute Disease; Animals; Bacteria; Bile; Chronic Disease; Disease Models, Animal; Enteritis; Indometh | 1993 |
Altered jejunal potassium (Rb+) transport in piglet rotavirus enteritis.
Topics: Acute Disease; Animals; Animals, Newborn; Biological Transport; Enteritis; Indomethacin; Jejunum; Ou | 1993 |
Decrease in systemic tolerance to fed ovalbumin in indomethacin-treated mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Enteritis; Femal | 1996 |
Superior mesenteric artery blood flow and indomethacin-induced intestinal injury and inflammation.
Topics: Animals; Blood Pressure; Enteritis; Indomethacin; Intestine, Small; Male; Peroxidase; Rats; Rats, Sp | 1996 |
Bile secretion in rats with indomethacin-induced intestinal inflammation.
Topics: Animals; Bile; Bile Acids and Salts; Blood; Clindamycin; Enteritis; Horseradish Peroxidase; Indometh | 1996 |
Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dose-Response Rela | 1997 |
Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation.
Topics: Animals; Bile; Blood; Body Weight; Diet; Dose-Response Relationship, Drug; Eating; Enteritis; Indome | 1997 |
Dietary diosgenin attenuates subacute intestinal inflammation associated with indomethacin in rats.
Topics: Acute Disease; Animals; Bile; Bile Acids and Salts; Blood; Body Weight; Cholesterol; Diet; Diosgenin | 1997 |
Role of nitric oxide and platelet-activating factor in the initiation of indomethacin-provoked intestinal inflammation in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Enteritis; Ileum; Indomethacin; Jejunum; Male; Nit | 1998 |
Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Enteritis; Epithelial Cells; Female; Glucagon; Hum | 1999 |
Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Colitis; Enteritis; Enzyme | 2000 |
Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; DNA-Binding Proteins; Enteritis; Fucosy | 2000 |
In vivo assessment of villous microcirculation in the rat small intestine in indomethacin-induced inflammation: role of mast-cell stabilizer Ketotifen.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arterioles; Blood Flow Veloc | 2000 |
Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Cell Movement; Cytokines; | 2002 |
COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase | 2002 |
Indomethacin-induced intestinal inflammation.
Topics: Animals; Colchicine; Dexamethasone; DNA; Enteritis; Female; Ileum; Indomethacin; Intestinal Mucosa; | 1977 |
The effect of indomethacin on acute radiation induced gastrointestinal injury: a morphologic study.
Topics: Acute Disease; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enteritis; I | 1992 |
Enteric nerves mediate the fluid secretory response due to Salmonella typhimurium R5 infection in the rat small intestine.
Topics: Animals; Atropine; Enteritis; Hexamethonium; Hexamethonium Compounds; Ileum; Indomethacin; Intestina | 1987 |
Reiter's syndrome.
Topics: Adult; Africa; Arthritis, Reactive; Asia; Aspirin; Child, Preschool; Diagnosis, Differential; Dysent | 1974 |